410 related articles for article (PubMed ID: 28095749)
1. Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers.
Patel SS; Truong U; King M; Ferland A; Moreau KL; Dorosz J; Hokanson JE; Wang H; Kinney GL; Maahs DM; Eckel RH; Nadeau KJ; Cree-Green M
Vasc Med; 2017 Apr; 22(2):85-95. PubMed ID: 28095749
[TBL] [Abstract][Full Text] [Related]
2. Early Biomarkers of Subclinical Atherosclerosis in Obese Adolescent Girls with Polycystic Ovary Syndrome.
Hughan KS; Tfayli H; Warren-Ulanch JG; Barinas-Mitchell E; Arslanian SA
J Pediatr; 2016 Jan; 168():104-111.e1. PubMed ID: 26545724
[TBL] [Abstract][Full Text] [Related]
3. Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome.
Zueff LF; Martins WP; Vieira CS; Ferriani RA
Ultrasound Obstet Gynecol; 2012 Mar; 39(3):341-7. PubMed ID: 21898634
[TBL] [Abstract][Full Text] [Related]
4. Studies of cardiovascular risk factors in polycystic ovary syndrome patients combined with subclinical hypothyroidism.
Pei YJ; Wang AM; Zhao Y; Yan L; Li M; White RE; Han GC
Gynecol Endocrinol; 2014 Aug; 30(8):553-6. PubMed ID: 24884959
[TBL] [Abstract][Full Text] [Related]
5. Adolescents with Classical Polycystic Ovary Syndrome Have Alterations in the Surrogate Markers of Cardiovascular Disease but Not in the Endothelial Function. The Possible Benefits of Metformin.
Fruzzetti F; Ghiadoni L; Virdis A; De Negri F; Perini D; Bucci F; Giannarelli C; Gadducci A; Taddei S
J Pediatr Adolesc Gynecol; 2016 Oct; 29(5):489-495. PubMed ID: 27018756
[TBL] [Abstract][Full Text] [Related]
6. Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome.
Karbek B; Ozbek M; Karakose M; Topaloglu O; Bozkurt NC; Cakır E; Aslan MS; Delibasi T
J Ovarian Res; 2014 Mar; 7():31. PubMed ID: 24628831
[TBL] [Abstract][Full Text] [Related]
7. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
Meyer C; McGrath BP; Teede HJ
J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
[TBL] [Abstract][Full Text] [Related]
8. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
[TBL] [Abstract][Full Text] [Related]
9. Amino acid and fatty acid metabolomic profile during fasting and hyperinsulinemia in girls with polycystic ovarian syndrome.
Cree-Green M; Carreau AM; Rahat H; Garcia-Reyes Y; Bergman BC; Pyle L; Nadeau KJ
Am J Physiol Endocrinol Metab; 2019 May; 316(5):E707-E718. PubMed ID: 30753112
[TBL] [Abstract][Full Text] [Related]
10. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome.
Lewy VD; Danadian K; Witchel SF; Arslanian S
J Pediatr; 2001 Jan; 138(1):38-44. PubMed ID: 11148510
[TBL] [Abstract][Full Text] [Related]
11. The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome.
Meun C; Gunning MN; Louwers YV; Peters H; Roos-Hesselink J; Roeters van Lennep J; Rueda Ochoa OL; Appelman Y; Lambalk N; Boersma E; Kavousi M; Fauser BC; Laven JS;
Clin Endocrinol (Oxf); 2020 Feb; 92(2):150-158. PubMed ID: 31638273
[TBL] [Abstract][Full Text] [Related]
12. Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype.
Armeni E; Stamatelopoulos K; Rizos D; Georgiopoulos G; Kazani M; Kazani A; Kolyviras A; Stellos K; Panoulis K; Alexandrou A; Creatsa M; Papamichael C; Lambrinoudaki I
J Hypertens; 2013 Oct; 31(10):1998-2004. PubMed ID: 24107731
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing characteristics of metabolically healthy versus metabolically unhealthy obese adolescent girls with polycystic ovary syndrome.
Kim JY; Tfayli H; Michaliszyn SF; Lee S; Arslanian S
Fertil Steril; 2016 Jun; 105(6):1603-11. PubMed ID: 26921624
[TBL] [Abstract][Full Text] [Related]
14. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
[TBL] [Abstract][Full Text] [Related]
15. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure regulation and resting heart rate abnormalities in adolescent girls with polycystic ovary syndrome.
Zachurzok-Buczynska A; Szydlowski L; Gawlik A; Wilk K; Malecka-Tendera E
Fertil Steril; 2011 Dec; 96(6):1519-25. PubMed ID: 22032814
[TBL] [Abstract][Full Text] [Related]
17. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease.
Arslanian SA; Lewy VD; Danadian K
J Clin Endocrinol Metab; 2001 Jan; 86(1):66-71. PubMed ID: 11231980
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease risk in young Indian women with polycystic ovary syndrome.
Guleria AK; Syal SK; Kapoor A; Kumar S; Tiwari P; Dabadghao P
Gynecol Endocrinol; 2014 Jan; 30(1):26-9. PubMed ID: 24020937
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular myocardial mass index and its correlates as an early marker of cardiovascular risk among nonobese normotensive Indian women with polycystic ovary syndrome: lessons from a cross-sectional study.
Rashid A; Masood A; Wani IA; Hafeez I; Parvez T; Zagar MA; Ganie MA
Fertil Steril; 2020 Jun; 113(6):1299-1307.e2. PubMed ID: 32482259
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonographic evaluation of intra-abdominal fat distribution and study of its influence on subclinical atherosclerosis in women with polycystic ovarian syndrome.
Tripathy P; Sahu A; Sahu M; Nagy A
Eur J Obstet Gynecol Reprod Biol; 2017 Oct; 217():18-22. PubMed ID: 28850821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]